Therapix Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.12.19	Healthcare Stocks That Plunged To New Lows (PTGX, TRPX, MTP...) (RTTNews)
24.07.19	6 Top Gainers In Healthcare Sector (HOTH, CHMA, TRPX…) (RTTNews)
05.02.19	7 Top Gainers In Healthcare Sector (ALRN, APHA, INSY...) (RTTNews)
06.11.18	TRPX On A High, PBYI Braces For Busy Times Ahead, NVCN On Watch (RTTNews)
24.10.18	CORV Is Back, SENS' Eversense Gets Aetna Coverage, ACRX Nears FDA Decision Day (RTTNews)
23.10.18	ABBV ACHIEVES Goals, HealthStream's CFO Resigns, NTEC On Watch (RTTNews)
03.10.18	OGEN Spikes 200% In 2 Days, TRPX On A High, INO Turning Heads (RTTNews)
21.09.18	ALT Up 514% In 2 Days, CRBP Well Stocked, ACAD Soars On FDA Review (RTTNews)
05.09.18	MNKD Takes Giant Leap, REPH On Watch, ALRN To Report Study Data In Q4 (RTTNews)
30.08.18	GKOS Gains On Rival's Loss, TRPX Turns Heads, ZYNE Back On Track, SPHS On Watch (RTTNews)
21.08.18	AMRX Soars On Contract Win, TRPX Looks Ahead With Hope, ALXN To Face FDA In Feb (RTTNews)
11.06.18	Therapix Biosciences Sponsors the 2018 Annual Meeting of the European Society for the Study of Tourette Syndrome (PR Newswire)
06.06.18	BIIB's Alzheimer's Drug Scores Well, EXAS Heads Higher, VXRT Down But Not Out (RTTNews)
05.06.18	Therapix Biosciences Announces Enrollment of the First Patient for Clinical Trial at Assuta Medical Center for Treating Obstructive Sleep Apnea Using Cannabinoid-based Drug (PR Newswire)
01.06.18	CLSD Dims, SCPH Disappoints, ZEAL On Track, All Eyes On MRTX (RTTNews)
31.05.18	Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update (PR Newswire)
15.05.18	Therapix Biosciences Issues CEO's Letter to Shareholders (PR Newswire)
09.05.18	Dual-Listed Therapix to Voluntarily Delist from Tel Aviv Stock Exchange (PR Newswire)
10.04.18	ABBV's SELECT-COMPARE Hits Goals, MNLO's ATOMIK Flops, VTVT Down 63% After-Hrs (RTTNews)
09.04.18	Therapix Biosciences Announces Topline Results of Phase IIa Study at Yale University for Tourette Syndrome Program (PR Newswire)
21.03.18	FDA Nod For SGEN's Adcetris, Antibe Soars On GI Data, CHMA Empowered (RTTNews)
20.03.18	Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain (PR Newswire)
07.02.18	Therapix Biosciences Completes Pre-IND Communication With FDA on THX-110 for Tourette Syndrome: Clinical Development to Proceed as Projected (PR Newswire)
09.01.18	Therapix Biosciences Announces Expansion into Precision Medicine Through New Fully-Owned Subsidiary and Provides Corporate Update Today at the Biotech Showcase™ 2018 (PR Newswire)
04.12.17	Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program (PR Newswire)
21.11.17	Therapix Biosciences Spotlighted in Financial and Trade Media Outlets (PR Newswire)
10.11.17	Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two Innovative Synthetic Cannabinoids (PR Newswire)
09.11.17	Therapix Biosciences Reports Third Quarter 2017 Financial Results and Provides Business Update (PR Newswire)
07.11.17	Therapix to Present at and Attend Investor Conferences in London (PR Newswire)
02.11.17	Therapix Biosciences Third Quarter 2017 Conference Call and Webcast Scheduled for Thursday, November 9, 2017 (PR Newswire)
02.11.17	Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer (PR Newswire)
30.10.17	Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd (PR Newswire)
30.10.17	Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd (PR Newswire)
30.10.17	Therapix Biosciences Initiates Non-clinical Studies for its Antibacterial Program in Collaboration With the Weizmann Institute of Science and Tel Aviv Sourasky Medical Center (PR Newswire)
18.10.17	Therapix Biosciences and Assuta Medical Center to Initiate Clinical Trial in Obstructive Sleep Apnea (PR Newswire)
06.10.17	Therapix Signs Formulation Development and Clinical Manufacturing Agreement with Catalent for THX-TS01 (PR Newswire)
27.09.17	Therapix's First-in-Class Therapy Demonstrates Reversal of Age-Related Cognitive Impairment in Pre-Clinical Study (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
10.08.17	Therapix Biosciences Reports Second Quarter 2017 Financial Results and Provides Business Update (PR Newswire)
03.08.17	Therapix Biosciences Second Quarter 2017 Conference Call and Webcast Scheduled for Thursday, August 10, 2017 (PR Newswire)
11.07.17	Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
11.07.17	Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
11.07.17	CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids (PR Newswire)
27.06.17	Therapix Biosciences to Ring the Nasdaq Stock Market Opening Bell on June 28 (PR Newswire)
30.05.17	Therapix Biosciences to Present at Upcoming Scientific and Investor Conferences in June (PR Newswire)
24.05.17	Therapix Biosciences Announces CEO Change (PR Newswire)
08.05.17	Therapix Biosciences and the Hannover Medical School Enter into an Investigator-initiated Clinical Trial Agreement to Assess the Effect of TXH-TS01 in Patients with Tourette Syndrome (PR Newswire)
03.05.17	Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer (PR Newswire)
05.04.17	Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	125.85	2.57 %	K V
Sika	232.30	1.84 %	K V
Swiss Re	132.20	1.58 %	K V
Logitech Intl	72.56	1.48 %	K V
ABB	51.02	1.47 %	K V
Nestle	76.60	0.16 %	K V
Sonova Hldg	300.80	0.00 %	K V
Novartis	93.14	-0.14 %	K V
Swisscom	507.00	-0.29 %	K V
Alcon	78.06	-0.41 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Therapix Biosciences Ltd (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten